(175) explored the combined efficacy of third-generation EGFR-specific CAR-NK-92 cells transduced by lentiviral and the chemotherapeutic drug cabozantinib in a mouse model of human RCC (175). The gene discussed is EGFR; the disease is renal cell carcinoma.